# Should a Group Practice Buy a Standalone AI Scribe or an EHR With AI Built In?

By Steven Van · 2026-09-18

Oasys argues group practices should weigh the extra business associate, chart copy-paste and billing gaps before choosing a standalone AI scribe.

A group practice weighing a standalone AI scribe against an EHR with AI built in is making a data-flow decision, according to [Oasys Health](<https://creatorstoolbox.com/resources/oasys-health>). In a [new article](<https://oasys.health/blog/standalone-ai-scribe-vs-ehr-with-ai-built-in>), Oasys argues the comparison is less about transcription quality and more about what happens to the note before and after it is written.

## A second vendor for every session

A standalone scribe such as Mentalyc, Upheal or Blueprint is its own HIPAA business associate. It has its own BAA, its own audio and transcript retention policy and its own data-handling practices. A practice has to ask the same due-diligence questions twice, once for the scribe and once for the EHR. With AI built into the EHR there is one vendor relationship to evaluate.

## Copy-paste and billing

- **Chart:** a standalone scribe produces the note in its own interface, so someone, usually the clinician, has to move it into the chart. Oasys writes the AI-drafted note directly into the chart it belongs to.

- **Claims:** a standalone scribe that is not connected to billing stops at the note, and the CPT code, diagnosis code and claim are produced elsewhere, usually by hand. Oasys generates the CPT-coded claim from the signed note.

## When a standalone scribe still fits

Oasys names three cases: a practice happy with its current EHR that does not want to migrate just to get AI documentation, a practice that needs a specialty-specific scribe (psychiatry tools, for example) that a general EHR's built-in AI does not match, and a solo practice testing whether AI documentation helps before switching EHRs. It says the calculus changes at group-practice scale, where the copy-paste and billing gaps multiply across every clinician.

## Questions to ask before choosing

- Is the AI tool a named HIPAA business associate with its own BAA, and has the practice seen it?

- Does the drafted note land in the chart automatically, or does a clinician move it?

- Does the note connect to a claim, or is coding and submission done separately?

- If the practice likes its EHR and only wants AI added, does the EHR have a credible native roadmap, or is a standalone tool the only real option today?

## How Oasys handles it

Oasys says its AI documentation is native rather than a connected third-party product. The drafted note lands in the chart, audio is not stored beyond the live transcription window, consent is tracked per client, and the signed note generates the CPT-coded claim. The article also notes that neither approach is inherently more secure, since both depend on the actual BAA and retention practices, which a practice should verify directly.

[![](<https://cdn.sanity.io/images/g5h91bwc/production/774956b26a93bf08d611ebd53ba777703132d94f-1600x900.png>)](<https://oasys.health/blog/standalone-ai-scribe-vs-ehr-with-ai-built-in>)

![Oasys Health](<https://www.google.com/s2/favicons?domain=oasys.health&sz=128>)

Oasys Health

The operating system for modern mental healthcare — AI-powered clinical notes, scheduling, billing, and patient management in one HIPAA-compliant platform.

[View Oasys Health →](<https://creatorstoolbox.com/resources/oasys-health>)

Sources

[Original source](<https://oasys.health/blog/standalone-ai-scribe-vs-ehr-with-ai-built-in>)

[Read Should a Group Practice Buy a Standalone AI Scribe or an EHR With AI Built In? on Creators Toolbox](<https://creatorstoolbox.com/blog/oasys-health-should-a-group-practice-buy-a-standalone-ai-scribe-or-an-ehr>)

---
Canonical source: https://creatorstoolbox.com/blog/oasys-health-should-a-group-practice-buy-a-standalone-ai-scribe-or-an-ehr